| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Jan 25 | NTLA Intellia Therapeutics | Common Stock | Sell | Dispose S | No | No | 12.18 | 9,557 | 116.40 k | 87,666 |
| 1 Jan 25 | NTLA Intellia Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,189 | 0.00 | 97,223 |
| 1 Jan 25 | NTLA Intellia Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 3,189 | 0.00 | 0 |
| 1 Mar 24 | NTLA Intellia Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 38,701 | 0.00 | 93,073 |
| 1 Mar 24 | NTLA Intellia Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 32.66 | 55,855 | 1.82 mm | 55,855 |
| 3 Jan 24 | NTLA Intellia Therapeutics | Common Stock | Sell | Dispose S | No | No | 29.46 | 5,843 | 172.13 k | 54,372 |
| 1 Jan 24 | NTLA Intellia Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,187 | 0.00 | 60,215 |
| 1 Jan 24 | NTLA Intellia Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 3,187 | 0.00 | 3,189 |
